JAmCollNutr.37(1),51-59
#MedicalLaboratoryScience #Hematology To view or add a comment, sign in #HFSA2025: Combination therapy with #Tafamidis and #Patisiran did not significantly improve survival or reduce #HeartFailure events compared with #TafamidisMonotherapy in patients with transthyretin amyloid cardiomyopathy (#ATTRCM), according to new findings presented at the Heart Failure Society of America Annual Scientific Meeting 2025
El-Yassimi, A., Hichami, A., Besnard, P
TRIUMPH-1 extended this picture significantly: TRIUMPH-4 trajectory (68 weeks): Week 68: 28.7% weight loss Note: Intermediate timepoint data (weeks 2448) was not reported in the December 2025 topline release
Even if theyre listing the right ingredients, you dont know where these ingredients are from or how theyve been transported or handled, which could be really dangerous. Lin and Ramachandran recommend that anyone seeking GLP-1 drugs consult with a physician both before they start and while theyre taking the medication to manage potential side effects, ensure safety and to make sure medication they receive is FDA-approved
You never want to take two doses in one week. If you miss two or more weeks of medication Once youve missed two doses of GLP-1 medication, its challenging to know just how much of the drug remains in your system